Obesity Pill Revolution: Daily Tablet Challenges Injections
A new daily obesity pill, Foundavo, gains FDA approval in the U.S., with Britain likely to follow. This oral alternative to weekly GLP-1 injections could transform weight loss treatment, offering convenience and potentially lower costs amid rising demand.


